Nolvadex 10 - Prime Pharma

Tamoxifen citrate, a potent SERM, was developed by ICI in 1962 and later marketed as Nolvadex. Initially researched for infertility, it became a key drug for treating estrogen receptor-positive breast cancer after gaining FDA approval in 1977. Tamoxifen functions by blocking estrogen receptors in breast tissue, preventing cancer cell growth. Beyond oncology, it is popular in bodybuilding circles to counteract gynecomastia during steroid cycles. Additionally, its partial estrogenic activity in the liver helps maintain HDL cholesterol levels, offering cardiovascular support during post-cycle therapy .

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Nolvadex 10 by Prime Pharma, consult with your doctor or healthcare professional.